|
1
|
Sun J: D-Limonene: safety and clinical
applications. Altern Med Rev. 12:259–264. 2007.PubMed/NCBI
|
|
2
|
Hakim IA, Harris RB and Ritenbaugh C:
Citrus peel use is associated with reduced risk of squamous cell
carcinoma of the skin. Nutr Cancer. 37:161–168. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maltzman TH, Hurt LM, Elson CE, Tanner MA
and Gould MN: The prevention of nitrosomethylurea-induced mammary
tumors by d-limonene and orange oil. Carcinogenesis. 10:781–783.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Elson CE, Maltzman TH, Boston JL, Tanner
MA and Gould MN: Anti-carcinogenic activity of d-limonene during
the initiation and promotion/progression stages of DMBA-induced rat
mammary carcinogenesis. Carcinogenesis. 9:331–332. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Uedo N, Tatsuta M, Iishi H, et al:
Inhibition by D-limonene of gastric carcinogenesis induced by
N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Lett.
137:131–136. 1999.PubMed/NCBI
|
|
6
|
Giri RK, Parija T and Das BR: d-limonene
chemoprevention of hepatocarcinogenesis in AKR mice: Inhibition of
c-jun and c-myc. Oncol Rep. 6:1123–1127. 1999.PubMed/NCBI
|
|
7
|
Nakaizumi A, Baba M, Uehara H, Iishi H and
Tatsuta M: d-Limonene inhibits N-nitrosobis(2-oxopropyl)amine
induced hamster pancreatic carcinogenesis. Cancer Lett. 117:99–103.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wattenberg LW, Sparnins VL and Barany G:
Inhibition of N-nitrosodiethylamine carcinogenesis in mice by
naturally occurring organosulfur compounds and monoterpenes. Cancer
Res. 49:2689–2692. 1989.PubMed/NCBI
|
|
9
|
Vigushin DM, Poon GK, Boddy A, et al:
Phase I and pharmacokinetic study of D-limonene in patients with
advanced cancer. Cancer Research Campaign Phase I/II Clinical
Trials Committee. Cancer Chemother Pharmacol. 42:111–117. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steele VE, Kelloff GJ, Wilkinson BP and
Arnold JT: Inhibition of transformation in cultured rat tracheal
epithelial cells by potential chemopreventive agents. Cancer Res.
50:2068–2074. 1990.PubMed/NCBI
|
|
11
|
Maltzman TH, Christou M, Gould MN and
Jefcoate CR: Effects of monoterpenoids on in vivo DMBA-DNA adduct
formation and on phase I hepatic metabolizing enzymes.
Carcinogenesis. 12:2081–2087. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Van der Logt EM, Roelofs HM, van Lieshout
EM, Nagengast FM and Peters WH: Effects of dietary anticarcinogens
and nonsteroidal anti-inflammatory drugs on rat gastrointestinal
UDP-glucuronosyltransferases. Anticancer Res. 24:843–849.
2004.PubMed/NCBI
|
|
13
|
Manuele MG, Barreiro Arcos ML, Davicino R,
Ferraro G, Cremaschi G and Anesini C: Limonene exerts
antiproliferative effects and increases nitric oxide levels on a
lymphoma cell line by dual mechanism of the ERK pathway:
relationship with oxidative stress. Cancer Invest. 28:135–145.
2010. View Article : Google Scholar
|
|
14
|
Lu XG, Zhan LB, Feng BA, Qu MY, Yu LH and
Xie JH: Inhibition of growth and metastasis of human gastric cancer
implanted in nude mice by d-limonene. World J Gastroenterol.
10:2140–2144. 2004.PubMed/NCBI
|
|
15
|
Hata T, Sakaguchi I, Mori M, et al:
Induction of apoptosis by Citrus paradisi essential oil in human
leukemic (HL-60) cells. In Vivo. 17:553–559. 2003.PubMed/NCBI
|
|
16
|
Ji J, Zhang L, Wu YY, Zhu XY, Lv SQ and
Sun XZ: Induction of apoptosis by d-limonene is mediated by a
caspase-dependent mitochondrial death pathway in human leukemia
cells. Leuk Lymphoma. 47:2617–2624. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Franke TF, Hornik CP, Segev L, Shostak GA
and Sugimoto C: PI3K/Akt and apoptosis: size matters. Oncogene.
22:8983–8998. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bader AG, Kang S, Zhao L and Vogt PK:
Oncogenic PI3K deregulates transcription and translation. Nat Rev
Cancer. 5:921–929. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niedermeier M, Hennessy BT, Knight ZA, et
al: Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit
CXCR4 signaling and overcome stromal cell-mediated drug resistance
in chronic lymphocytic leukemia: a novel therapeutic approach.
Blood. 113:5549–5557. 2009.
|
|
20
|
Cui B, Tao J and Yang Y: Studies on the
expression patterns of class I PI3K catalytic subunits and its
prognostic significance in colorectal cancer. Cell Biochem Biophys.
62:47–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Page C, Lin HJ, Jin Y, et al:
Overexpression of Akt/AKT can modulate chemotherapy-induced
apoptosis. Anticancer Res. 20:407–416. 2000.PubMed/NCBI
|
|
22
|
Opel D, Naumann I, Schneider M, Bertele D,
Debatin KM and Fulda S: Targeting aberrant PI3K/Akt activation by
PI103 restores sensitivity to TRAIL-induced apoptosis in
neuroblastoma. Clin Cancer Res. 17:3233–3247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garcia-Echeverria C and Sellers WR: Drug
discovery approaches targeting the PI3K/Akt pathway in cancer.
Oncogene. 27:5511–5526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Crowder RJ and Freeman RS: Glycogen
synthase kinase-3 beta activity is critical for neuronal death
caused by inhibiting phosphatidylinositol 3-kinase or Akt but not
for death caused by nerve growth factor withdrawal. J Biol Chem.
275:34266–34271. 2000. View Article : Google Scholar
|
|
25
|
Szanto A, Bognar Z, Szigeti A, Szabo A,
Farkas L and Gallyas F Jr: Critical role of bad phosphorylation by
Akt in cytostatic resistance of human bladder cancer cells.
Anticancer Res. 29:159–164. 2009.PubMed/NCBI
|
|
26
|
Cardone MH, Roy N, Stennicke HR, et al:
Regulation of cell death protease caspase-9 by phosphorylation.
Science. 282:1318–1321. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim SH, Park EJ, Lee CR, et al: Geraniol
induces cooperative interaction of apoptosis and autophagy to
elicit cell death in PC-3 prostate cancer cells. Int J Oncol.
40:1683–1690. 2012.PubMed/NCBI
|
|
28
|
Chaudhary SC, Siddiqui MS, Athar M and
Alam MS: D-Limonene modulates inflammation, oxidative stress and
Ras-ERK pathway to inhibit murine skin tumorigenesis. Hum Exp
Toxicol. 31:798–811. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaji I, Tatsuta M, Iishi H, Baba M, Inoue
A and Kasugai H: Inhibition by d-limonene of experimental
hepatocarcinogenesis in Sprague-Dawley rats does not involve
p21(ras) plasma membrane association. Int J Cancer. 93:441–444.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rabi T and Bishayee A: d-Limonene
sensitizes docetaxel-induced cytotoxicity in human prostate cancer
cells: Generation of reactive oxygen species and induction of
apoptosis. J Carcinog. 8:92009. View Article : Google Scholar
|
|
31
|
Khan N, Adhami VM and Mukhtar H: Apoptosis
by dietary agents for prevention and treatment of cancer. Biochem
Pharmacol. 76:1333–1339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsieh CC, Hernandez-Ledesma B and de Lumen
BO: Lunasin, a novel seed peptide, sensitizes human breast cancer
MDA-MB-231 cells to aspirin-arrested cell cycle and induced
apoptosis. Chem Biol Interact. 186:127–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun SY, Hail N Jr and Lotan R: Apoptosis
as a novel target for cancer chemoprevention. J Natl Cancer Inst.
96:662–672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baysan A, Yel L, Gollapudi S, Su H and
Gupta S: Arsenic trioxide induces apoptosis via the mitochondrial
pathway by upregulating the expression of Bax and Bim in human B
cells. Int J Oncol. 30:313–318. 2007.PubMed/NCBI
|
|
35
|
Uren RT, Dewson G, Chen L, et al:
Mitochondrial permeabilization relies on BH3 ligands engaging
multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol.
177:277–287. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen M, Guerrero AD, Huang L, et al:
Caspase-9-induced mitochondrial disruption through cleavage of
anti-apoptotic BCL-2 family members. J Biol Chem. 282:33888–33895.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Krystal GW, Sulanke G and Litz J:
Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks
growth, promotes apoptosis, and enhances sensitivity of small cell
lung cancer cells to chemotherapy. Mol Cancer Ther. 1:913–922.
2002.PubMed/NCBI
|
|
38
|
Liu X, Shi Y, Giranda VL and Luo Y:
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway
sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced
apoptosis. Mol Cancer Ther. 5:494–501. 2006. View Article : Google Scholar : PubMed/NCBI
|
